SCCF Sachem reports strong Q4 2025 EPS results far above estimates share price remains unchanged today AbbVie Inc ABBV Submits SKYRIZI Subcutaneous Crohns Regimen to FDA But NearTerm Upside Remains Capped By Competitive Risks ARTCU Art Tech Acq management notes healthy deal pipeline as it evaluates technology sector acquisition targets